Product Information

CYCLOBENZAPRINE 5 MG TABLET is a generic product labeled by Cipla USA Inc., priced at $0.0211 per EA under NDC 69097084507. Its NADAC has been published 511 times since Sep 14, 2016.

The High Outlier badge above means this manufacturer's average price in the Cyclobenzaprine market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

CYCLOBENZAPRINE 5 MG TABLET

Cyclobenzaprine
$0.0211per EA
High Outlier

Strength

5 mg/1

Manufacturer

Cipla USA Inc.

NDC

69097084507

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Last Updated

6/17/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA090478

On Market Since

7/22/2016

Pharmacological Classes

Centrally-mediated Muscle Relaxation
Muscle Relaxant

Price Statistics

The NADAC for CYCLOBENZAPRINE 5 MG TABLET has been published 511 times since Sep 14, 2016, and over the history we have for it it has declined 54.1%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0211 per EA
All-time high$0.0470 (Jan 11, 2017)
All-time low$0.0157 (Nov 20, 2024)
52-week high$0.0220
52-week low$0.0209
Median price$0.0313
Average price$0.0298
Largest weekly change+36.3% (Aug 21, 2024)
Weeks tracked511
Tracking sinceSep 14, 2016

Price History

1W

0.0%

1M

-1.0%

3M

+1.1%

6M

-2.8%

1Y

-3.9%

3Y

-9.2%

5Y

-36.9%

All

-54.1%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the Cyclobenzaprine market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Frequently asked questions

What is the NADAC price of CYCLOBENZAPRINE 5 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for CYCLOBENZAPRINE 5 MG TABLET, manufactured by Cipla USA Inc., is $0.0211 per EA (NDC 69097084507), effective Jun 24, 2026.

How has the price of CYCLOBENZAPRINE 5 MG TABLET changed over time?

Over the history we have for it, the NADAC for CYCLOBENZAPRINE 5 MG TABLET has declined 54.1%. It has been tracked across 511 weekly CMS publications since Sep 14, 2016.

What are the highest and lowest recorded NADAC prices for CYCLOBENZAPRINE 5 MG TABLET?

Since Sep 14, 2016, the NADAC for CYCLOBENZAPRINE 5 MG TABLET has ranged from a low of $0.0157 (Nov 20, 2024) to a high of $0.0470 (Jan 11, 2017), with a median of $0.0313 per EA.

Are there cheaper alternatives to CYCLOBENZAPRINE 5 MG TABLET?

No other NADAC-published product currently shares the active ingredient, strength, and dosage form of CYCLOBENZAPRINE 5 MG TABLET, so no direct lower-cost alternative is listed.

Who manufactures CYCLOBENZAPRINE 5 MG TABLET?

CYCLOBENZAPRINE 5 MG TABLET (NDC 69097084507) is labeled by Cipla USA Inc., and CMS classifies it as a generic product.